NEW YORK (GenomeWeb) – Cancer diagnostics developer Metamark Genetics announced today that it has signed a coverage deal for its urological cancer diagnostics with Blue Cross and Blue Shield of Texas, effective June 1.

The agreement covers all of BCBS insured members in Texas and gives them access to Metamark's array of urology specialized diagnostics.

Specific terms of the deal were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.